As we look forward to the 2017 International Neuroethics Society (INS) Annual Meeting in Washington, DC, November 9-10, we’ll be bringing you a sneak peek of what to expect through a series of interviews with some of the meetings’ speakers. Registration for the meeting is now open, and an early bird discount is in effect until September 30.
First published in the INS Newsletter:
Rémi Quirion, the first Chief Scientist of Québec, will give a plenary lecture at the 2017 Annual Meeting in Washington, D.C. His research lies in the field of neuropharmacology, specifically in relation to aging and neurological diseases such as dementia and Alzheimer’s.
How did you become interested in or involved with this type of research?
My research lab was based in a mental health hospital. There I was surrounded by many people suffering from various types of mental illnesses and neurological disease, so it familiarized me with different issues related to mental health and exposed me to the line between neuroscience and ethics, which I sought to understand more and more in the treatment of mental illnesses.